REVIEW
|
doi:10.20944/preprints202405.0203.v1
Subject:
Epidemiology And Infectious Diseases,
Medicine And Pharmacology
Keywords:
Acinetobacter baumannii; carbapenem-resistance; sulbactam-durlobactam; cefiderocol; guidelines; real-world evidence
Online: 6 May 2024 (08:47:22 CEST)